in this issue
People & Business :: People/Executives
Merck KGaA announces multiple management changes in its pharmaceutical businesses
September 26, 2013 | Deepti Ramesh
Merck KGaA (Darmstadt, Germany) today announced multiple management and organizational changes in its pharmaceutical businesses. Belén Garijo, currently COO at Merck Serono (Geneva), the biopharmaceutical division of Merck KGaA, has been appointed president and CEO of Merck Serono, effective 1 October. She will succeed Stefan Oschmann, who, as member of the executive board and head/pharmaceuticals at Merck, will focus on further developing the Merck Serono and consumer health divisions as well as the allergopharma and biosimilars units. All four...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be: